SCHEMBL7980271

SCHEMBL7980271

ClCCN(C1CCCCC1)C1CCCCC1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADH1A P07327 7/20 0.35
ALDH1A1 P00352 5/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2D6 P10635 1/20 0.35
CYP2C9 P11712 1/20 0.35
SLC6A2 P23975 1/20 0.35
SLC6A4 P31645 1/20 0.35
CYP2C19 P33261 1/20 0.35
SLC6A3 Q01959 1/20 0.35
MEN1 O00255 5/20 0.33
KMT2A Q03164 5/20 0.33
ADH1C P00326 4/20 0.33
SMN1; SMN2 Q16637 3/20 0.33
GAA P10253 1/20 0.33
ADRA2A P08913 1/20 0.33
PDE4A P27815 1/20 0.33
ADRA1A P35348 1/20 0.33
KDM4E B2RXH2 1/20 0.32
NPC1 O15118 1/20 0.32
MITF O75030 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11874061 0.97 ADH1A (0.33) ADH1AALDH1A1CYP3A4CYP2D6CYP2C9
SCHEMBL10170019 0.85 ADH1A (0.39) ADH1AALDH1A1CYP3A4CYP2D6CYP2C9
SCHEMBL10170018 0.80 SIGMAR1 (0.38) ADH1AALDH1A1CYP3A4CYP2D6CYP2C9
SCHEMBL6567468 0.78 CYP2D6 (0.38) ADH1AALDH1A1CYP2D6CYP2C9CYP2C19
SCHEMBL10170022 0.78 SIGMAR1 (0.41) ADH1AALDH1A1CYP3A4CYP2D6CYP2C9
SCHEMBL10171077 0.78 SIGMAR1 (0.41) ADH1AALDH1A1CYP3A4CYP2D6CYP2C9
SCHEMBL10171075 0.78 SIGMAR1 (0.41) ADH1AALDH1A1CYP3A4CYP2D6CYP2C9
SCHEMBL11882851 0.77 ALDH1A1 (0.39) ALDH1A1SMN1; SMN2ADRA2ALMNA
SCHEMBL24158306 0.76 ADH1A (0.54) ADH1AALDH1A1MEN1KMT2AADH1C
SCHEMBL2067548 0.76 ADH1A (0.54) ADH1AALDH1A1MEN1KMT2AADH1C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6235730-B1 ANTICHOLESTEROL AGENT, ANTILIPEMIC AGENT JAPAN TOBACCO, INC. (JP) 2001-05-22 US disclosed
EP-0970954-A1 3-PIPERIDYL-4-OXOQUINAZOLINE DERIVATIVES AND MEDICINCAL COMPOSITIONS CONTAINING THE SAME JAPAN TOBACCO INC. (JP) 2000-01-12 EP disclosed
US-3960886-A Substituted N-arylanilines STERLING DRUG INC. (US) 1976-06-01 US disclosed